Home
Conditions
Dermatitis, Seborrheic

Clinical trial condition

Dermatitis, Seborrheic

Explore clinical trials studying Dermatitis, Seborrheic. Study availability and eligibility vary by location and protocol.

42 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Dermatitis, Seborrheic trial results

Completed

Ruxolitinib in Seborrheic Dermatitis

NCT05787860

Conditions: Dermatitis, Dermatitis, Seborrheic, Sebaceous Gland Diseases, +5 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult

NCT03830177

Conditions: Dermatitis, Dermatitis, Seborrheic, Dry Skin; Eczema, +6 more
Locations: Medical Dermatology Associates of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Efficacy of a Cosmetic Shampoo RV3438G in Reccurent Squamous States

NCT06578962

Conditions: Dermatitis, Dermatitis, Seborrheic, Sebaceous Gland Diseases, +4 more
Locations: Centre de Santé Sabouraud - Hôpital Saint Louis Paris, France

View Trial Details

Completed

A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

NCT03582137

Conditions: Anxiety Disorders, Basal Ganglia Diseases, Brain Diseases, +25 more
Locations: University of Colorado hospital Aurora, Colorado, United States

View Trial Details

Completed

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

NCT04445987

Conditions: Dermatitis, Dermatitis, Seborrheic, Sebaceous Gland Diseases, +5 more
Locations: Arcutis Biotherapeutics Clinical Site 59 Beverly Hills, California, United States

Arcutis Biotherapeutics Clinical Site 51 Encino, California, United States

Arcutis Biotherapeutics Clinical Site 75 Fountain Valley, California, United States

Arcutis Biotherapeutics Clinical Site 19 Fremont, California, United States

View all 39 locations

View Trial Details

Completed

Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis

NCT04472546

Conditions: Acne, Acne Vulgaris, Acneiform Eruptions, +19 more
Locations: Centre de Recherche sur la Peau Toulouse, France

View Trial Details

Completed

Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)

NCT04973228

Conditions: Dermatitis, Dermatitis, Seborrheic, Sebaceous Gland Diseases, +5 more
Locations: Arcutis Biotherapeutics Clinical Site 01 Scottsdale, Arizona, United States

Arcutis Biotherapeutics Clinical Site 45 Encinitas, California, United States

Arcutis Biotherapeutics Clinical Site 46 San Diego, California, United States

Arcutis Biotherapeutics Clinical Site 64 San Diego, California, United States

View all 53 locations

View Trial Details

Completed

Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

NCT04091646

Conditions: Dermatitis, Dermatitis, Seborrheic, Sebaceous Gland Diseases, +5 more
Locations: Arcutis Biotherapeutics Clinical Site 19 Fremont, California, United States

Arcutis Biotherapeutics Clinical Site 21 Santa Monica, California, United States

Arcutis Biotherapeutics Clinical Site 42 Coral Gables, Florida, United States

Arcutis Biotherapeutics Clinical Site 24 Miami, Florida, United States

View all 24 locations

View Trial Details

Completed

Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp

NCT05105139

Conditions: Dermatitis, Dermatitis, Seborrheic, Psoriasis of Scalp, +6 more
Locations: Laboratorio Silanes, S.A. de C.V. Mexico City, Mexico

View Trial Details

Completed

A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis

NCT00403559

Conditions: Dermatitis, Dermatitis, Seborrheic, Sebaceous Gland Diseases, +5 more
Locations: Dermatology Specialists Louisville, Kentucky, United States

View Trial Details

Dermatitis, Seborrheic

Dermatitis, Seborrheic trial results

Related conditions